Literature DB >> 12195186

Factors affecting local recurrence of colonic adenocarcinoma.

G J C Harris1, J M Church, A J Senagore, I C Lavery, T L Hull, S A Strong, V W Fazio.   

Abstract

PURPOSE: The aim of this retrospective study was to determine which aspects of tumor morphology and histology influenced the incidence of local recurrence after curative resection of colonic adenocarcinoma.
METHODS: Patients who had a curative resection for a primary colonic adenocarcinoma between 1980 and 1993 (inclusive) were identified from the colorectal cancer database in the Department of Colorectal Surgery. The charts of patients diagnosed with a local recurrence were then reviewed and their findings at operation and histologic assessment analyzed. Patients were followed up for at least five years or until death.
RESULTS: Over the period of study, 1,031 patients had a curative resection for colonic adenocarcinoma. Local recurrences were detected in 32 patients (3.1 percent). The gender distribution of patients with local recurrence was 18 males (56.3 percent) and 14 females (43.7 percent) with a mean age of 63.4 years. The median time to local recurrence was 13 (range, 2-71) months. The distribution of primary tumors that recurred locally favored the cecum (n = 9; 28.1 percent) and sigmoid colon (n = 14; 43.7 percent) over other locations; these were, however, the most common sites of primary lesions. Less common sites included the ascending colon (n = 0; 0 percent), hepatic flexure (n = 2; 6.3 percent), transverse colon (n = 1; 3.1 percent), splenic flexure (n = 3; 9.4 percent), and descending colon (n = 3; 9.4 percent). Of the total number of tumors, 101 were found to be adherent to at least 1 other intra-abdominal viscus, and 12 (11.9 percent) recurred locally. Other factors associated with local recurrence were tumor perforation and fistulation. Overall, 30 tumors (2.9 percent) were perforated, and 6 (20 percent) recurred locally. Four tumors (0.4 percent) were fistulating; of these, 2 (50 percent) recurred locally. Advanced tumor stage was also associated with an increased rate of local recurrence (Stage I, 0 percent; Stage II, 2.05 percent; Stage III, 7.0 percent; and Stage IV, 6.1 percent). Similarly, tumor differentiation was related to local recurrence, with no instances in well-differentiated tumors, 2.8 percent in moderately differentiated tumors, and 6.8 percent in poorly differentiated tumors.
CONCLUSIONS: The location of the primary tumor is not a factor in producing local recurrence. Fixity to another viscus, perforation or fistulation, advanced stage of disease, and differentiation of tumor appear to increase the chances of recurrence of curatively resected colonic carcinoma. Although the recurrence rate is higher in these groups than for tumors overall, definitive oncologic surgery prevents recurrence in the majority of cases. No colonic tumor that was T1 or T2 (N0, N1, or N2) or that was well differentiated recurred locally.

Entities:  

Mesh:

Year:  2002        PMID: 12195186     DOI: 10.1007/s10350-004-6355-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Colorectal cancer of the elderly.

Authors:  Lukejohn W Day; Fernando Velayos
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

2.  Postoperative recurrence and risk factors of colorectal cancer perforation.

Authors:  Hiroshi Asano; Kazuto Kojima; Naomi Ogino; Hiroyuki Fukano; Yasuhiro Ohara; Nozomi Shinozuka
Journal:  Int J Colorectal Dis       Date:  2016-10-30       Impact factor: 2.571

3.  Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.

Authors:  Wen-hong Xu; Yi-ding Chen; Yue Hu; Jie-kai Yu; Xian-guo Wu; Tie-jun Jiang; Shu Zheng; Su-zhan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2006-03       Impact factor: 3.066

4.  [Present treatment strategies for rectal carcinoma].

Authors:  T Liersch; C Langer; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

5.  Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy.

Authors:  Jae Young Kwak; Chan Wook Kim; Seok-Byung Lim; Chang Sik Yu; Tae Won Kim; Jong Hoon Kim; Se Jin Jang; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

6.  Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.

Authors:  Kotaro Sugawara; Yoshikuni Kawaguchi; Yukihiro Nomura; Daisuke Koike; Motoki Nagai; Nobutaka Tanaka
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

7.  Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.

Authors:  Ji-Cheng Zhang; Zuo-Ren Wang; Yan-Juan Cheng; Ding-Zhong Yang; Jing-Sen Shi; Ai-Lin Liang; Ning-Na Liu; Xiao-Min Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Local recurrence after curative resection in patients with colon and rectal cancers.

Authors:  H R Yun; L J Lee; J H Park; Y K Cho; Y B Cho; W Y Lee; H C Kim; H K Chun; S H Yun
Journal:  Int J Colorectal Dis       Date:  2008-08-08       Impact factor: 2.571

Review 9.  Colorectal cancer screening and surveillance in the elderly: updates and controversies.

Authors:  Lukejohn W Day; Fernando Velayos
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

10.  Predictors of recurrence free survival for patients with stage II and III colon cancer.

Authors:  Vassiliki L Tsikitis; David W Larson; Marianne Huebner; Christine M Lohse; Patricia A Thompson
Journal:  BMC Cancer       Date:  2014-05-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.